Biopharmaceutical Excipients Competitor Analysis Report - Global Forecast to 2026
The Global Biopharmaceutical Excipients Market size was estimated at USD 188.70 Million in 2020 and expected to reach USD 227.78 Million in 2021, at a Compound Annual Growth Rate (CAGR) 21.04% to reach USD 593.66 Million by 2026.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopharmaceutical Excipients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopharmaceutical Excipients Market, including ABITEC Corporation, Ashland Inc., Associated British Foods PLC, BASF SE, Clariant AG, Colorcon, Inc., DFE Pharma, Dow Chemical Company, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD, Innophos Holdings Inc.,, J. RETTENMAIER & SÖHNE GmbH + Co KG, JRS PHARMA, Meggle AG, Merck KGaA, Merck Millipore, Pharmonix Biological Pvt. Ltd, Roquette Frères, Sigachi Industries Pvt. Ltd., Spectrum Chemical Manufacturing Corp., SPI Pharma, The Lubrizol Corporation, and Wacker Chemie AG.
Our reports have been used by over 10K customers, including:
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2021 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product,...
Biopharmaceuticals Contract Manufacturing market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Biopharmaceuticals Contract Manufacturing Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Biopharmaceuticals...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the pegfilgrastim biosimilars market are Mylan, Biocon, Mundipharma, Pfizer, Sandoz, Coherus, Intas Pharmaceuticals, and Fresenius Kabi. The global pegfilgrastim biosimilars market is expected to grow from $0.8 billion in 2020 to $0.88 billion in 2021 at a compound annual growth rate (CAGR) of 10%. The growth is mainly...
The global eClinical Solutions market is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech...
The Global Antibody Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...
The Global Precision Medicine Partnering Terms and Agreements 2014-2021 report provides comprehensive understanding and unprecedented access to the Precision Medicine partnering deals and agreements entered into by the worlds leading healthcare companies. This report provides details of the latest Precision Medicine...
The Global Stem Cell Partnering Terms and Agreements 2010-2021 report provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in stem cell partnering Deal terms analysis Partnering agreement structure Partnering...
The global oxidative stress assay market reached a value of US$ 836 Million in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 9.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
Global TROP2 Antibody Market & Clinical Trials Insight 2026 Report Analysis and Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global TROP2 Antibody Market Opportunity Assessment: > USD 4 Billion • Market and Drug Sales Insight 2020 Till 2026 • Approved Drug In Market: 1 Drugs • Approved...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.